The Nasdaq Composite (NASDAQINDEX: ^IXIC) and the S&P 500 (SNPINDEX: ^GSPC) sank, shifting in and out of correction territory in the first quarter of the year for one big reason: investors have been ...

Collegium Pharmaceutical reported revenues of $181.9 million, up 21.5% year on year. This print exceeded analysts’ ...

Interface is poised for growth. Long-term prospects remain strong. TILE stock earns a Buy rating with strong earnings growth ...

This week’s picks cover: why even Tullow Oil’s base case looks decent, how Intuitive Surgical built a Med-Tech powerhouse, and why Barrick Gold can't wait for a commodity super-cycle.

NASA's SWOT satellite has revealed unseen ocean depths, mapping seafloor features that shape life, currents and tectonics.

Western Union's stock is undervalued, with a compelling risk-to-reward ratio and a nearly 9% yield, despite fintech ...

From plays *Manhunt* and *Punch* to musical *London Road*, these extraordinary productions all have a basis in real life.

OpenAI hits $300 billion as ChatGPT growth soars. Waymo expands robotaxi service with Uber partnership as Google's AI efforts ...

The Japanese gaming giant is about to release its latest console. The stakes have never been higher to end the boom-bust ...

I had no money growing up,” says Paul Gascoigne, in one of his many soliloquies about life and loss. “I haven’t got any now ...

When the British took control of Florida in 1763, St. Augustine already had extensive Spanish-built defenses, but British ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...